BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu L, Wang D, Wang J, Wang S. The Nitric Oxide Prodrug JS-K Induces Ca(2+)-Mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells. J Biochem Mol Toxicol 2016;30:192-9. [PMID: 26616367 DOI: 10.1002/jbt.21778] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Xu Y, Zhang W, Gao X, Luo G, Song H, Liu J, Wang H. Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics. Sci Rep 2021;11:10381. [PMID: 34001947 DOI: 10.1038/s41598-021-90001-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhang L, Dai J, Zeng Z, Jia Y. Nitric oxide induces HepG2 cell death via extracellular signal-regulated protein kinase activation by regulating acid sphingomyelinase. Mol Biol Rep 2020;47:8353-9. [PMID: 33025504 DOI: 10.1007/s11033-020-05881-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Nie Z, Deng S, Zhang L, Chen S, Lu Q, Peng H. Crocin protects against dexamethasone‑induced osteoblast apoptosis by inhibiting the ROS/Ca2+‑mediated mitochondrial pathway. Mol Med Rep 2019;20:401-8. [PMID: 31115574 DOI: 10.3892/mmr.2019.10267] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
4 Scicinski J, Kashfi K. Cancer and Beyond: Discovery and Development of NO-Releasing Therapeutics. Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders 2019. [DOI: 10.1016/b978-0-12-816545-4.00007-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Dong SC, Sha HH, Xu XY, Hu TM, Lou R, Li H, Wu JZ, Dan C, Feng J. Glutathione S-transferase π: a potential role in antitumor therapy. Drug Des Devel Ther 2018;12:3535-47. [PMID: 30425455 DOI: 10.2147/DDDT.S169833] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
6 Huang Z, Liu L, Chen J, Cao M, Wang J. JS-K as a nitric oxide donor induces apoptosis via the ROS/Ca2+/caspase-mediated mitochondrial pathway in HepG2 cells. Biomed Pharmacother 2018;107:1385-92. [PMID: 30257354 DOI: 10.1016/j.biopha.2018.08.142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
7 Liu L, Huang Z, Chen J, Wang J, Wang S. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2018;37:142. [PMID: 29986744 DOI: 10.1186/s13046-018-0823-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
8 Liu L, Huang Z, Chen J, Wang J, Wang S. Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells. J Cell Biochem 2018;119:6633-43. [PMID: 29693750 DOI: 10.1002/jcb.26845] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Qiu M, Ke L, Zhang S, Zeng X, Fang Z, Liu J. JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin. Cancer Chemother Pharmacol 2017;80:275-86. [DOI: 10.1007/s00280-017-3359-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
10 Liu Z, Li G, Gou Y, Xiao D, Luo G, Saavedra JE, Liu J, Wang H. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell. Biomed Pharmacother 2017;92:989-97. [PMID: 28605880 DOI: 10.1016/j.biopha.2017.05.141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]